Drug Type Cell therapy |
Synonyms |
Target |
Mechanism HSPGs modulators(Heparan sulfate proteoglycan protein modulators), MMPs inhibitors(Matrix metalloproteinase inhibitors), TGF-β1 modulators(Transforming growth factor beta 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - | |
Wounds and Injuries | Discovery | US | - |